ABSTRACT
Background and Aims Aerosol generating procedures have become an important healthcare issue due to the COVID-19 pandemic, as the SARS-CoV-2 virus can be transmitted via aerosols. We aimed to characterise aerosol and droplet generation in gastrointestinal endoscopy, where there is little evidence.
Methods This prospective observational study included patients undergoing routine per-oral gastroscopy (POG, n=36), trans-nasal endoscopy (TNE, n=11) and lower gastrointestinal (LGI) endoscopy (n=48). Particle counters took measurements near the appropriate orifice (two models used, diameter ranges 0.3μm-25μm and 20μm-3000μm). Quantitative analysis was performed by recording specific events and subtracting the background particles.
Results POG produced 1.96x the level of background particles (p<0.001) and TNE produced 2.00x (p<0.001) but a direct comparison shows POG produces 2.00x more particles than TNE. LGI procedures produce significant particle counts (p<0.001) with 2.4x greater production per procedure than POG but only 0.63x production per minute. Events significant relative to the room background particle count were: POG-throat spray (150.0x, p<0.001), oesophageal extubation (37.5x, p<0.001), coughing/gagging (25.8x, p<0.01); TNE-nasal spray (40.1x, p<0.001), nasal extubation (32.0x, p<0.01), coughing/gagging (20.0, p<0.01); LGI-rectal intubation (9.9x, p<0.05), rectal extubation (27.2x, p <0.01), application of abdominal pressure (9.6x, p <0.05), rectal insufflation/retroflexion (7.7x, p <0.01). These all produced particle counts larger than or comparable to volitional cough.
Conclusion Gastrointestinal endoscopy performed via the mouth, nose or rectum all generates significant quantities of aerosols and droplets. As the infectivity of procedures is not established, we therefore suggest adequate PPE is used for all GI endoscopy where there is a high population prevalence of COVID-19. Avoiding throat and nasal spray would significantly reduce particles generated from UGI procedures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors also thank Nottingham University Hospitals NHS Trust for funding the rental of the N60 spray characteriser and rental of a particle counter, and Norgine Pharmaceuticals for sponsoring the purchase of a particle counter. GSDG would like to acknowledge a UKRI Future Leaders Fellowship (MR/T041951/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Wales Research Ethics Committee - IRAS 285595
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.